247 related articles for article (PubMed ID: 28541601)
1. The approach to coronary bifurcation treatment and its outcomes in Poland: The single center experience.
Kern A; Gil RJ; Bojko K; Rzeszowski B; Jalali R; Górny J; Bil J
Cardiol J; 2017; 24(6):589-596. PubMed ID: 28541601
[TBL] [Abstract][Full Text] [Related]
2. Dedicated bifurcation stents or regular drug eluting stents in distal left main stenosis: A retrospective study.
Kern A; Gil RJ; Bojko K; Rzeszowski B; Bednarski K; Górny J; Bil J
Cardiol J; 2018; 25(2):188-195. PubMed ID: 28714525
[TBL] [Abstract][Full Text] [Related]
3. Regular Drug-Eluting Stent vs Dedicated Coronary Bifurcation BiOSS Expert Stent: Multicenter Open-Label Randomized Controlled POLBOS I Trial.
Gil RJ; Bil J; Džavík V; Vassilev D; Kern A; Formuszewicz R; Zalewska-Adamiec M; Dobrzycki S
Can J Cardiol; 2015 May; 31(5):671-8. PubMed ID: 25828372
[TBL] [Abstract][Full Text] [Related]
4. Comparison of dedicated BIOSS bifurcation stents with regular drug-eluting stents for coronary artery bifurcated lesions: Pooled analysis from two randomized studies.
Gil RJ; Bil J; Kern A; Iñigo Garcia LA; Formuszewicz R; Dobrzycki S; Vassilev D; Segiet A
Cardiol J; 2018; 25(3):308-316. PubMed ID: 28840591
[TBL] [Abstract][Full Text] [Related]
5. Regular drug-eluting stents versus the dedicated coronary bifurcation sirolimus-eluting BiOSS LIM® stent: the randomised, multicentre, open-label, controlled POLBOS II trial.
Gil RJ; Bil J; Grundeken MJ; Kern A; Iñigo Garcia LA; Vassilev D; Pawłowski T; Formuszewicz R; Dobrzycki S; Wykrzykowska JJ; Serruys PW
EuroIntervention; 2016 Dec; 12(11):e1404-e1412. PubMed ID: 26600564
[TBL] [Abstract][Full Text] [Related]
6. First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C® - three-month results.
Gil RJ; Bil J; Kern A; Pawłowski T
Kardiol Pol; 2018; 76(2):464-470. PubMed ID: 29192951
[TBL] [Abstract][Full Text] [Related]
7. Angiographic and clinical outcomes after implantation of drug eluting stents in bifurcation lesions with crush or kissing stent technique.
Cheema AN; Jolly SS; Burstein JM; Sharieff W; Mohammad A; Yeoh E; Mancini GB; Cantor WJ; Kutryk MJ; Strauss BH; Chisholm RJ
J Interv Cardiol; 2013 Apr; 26(2):145-52. PubMed ID: 23406435
[TBL] [Abstract][Full Text] [Related]
8. Angiographic Restenosis in Coronary Bifurcations Treatment with Regular Drug Eluting Stents and Dedicated Bifurcation Drug-Eluting BiOSS Stents: Analysis Based on Randomized POLBOS I and POLBOS II Studies.
Gil RJ; Bil J; Kern A; Iñigo-Garcia LA; Formuszewicz R; Dobrzycki S; Vassilev D; Mehran R
Cardiovasc Ther; 2020; 2020():6760205. PubMed ID: 32411301
[TBL] [Abstract][Full Text] [Related]
9. Long-Term Outcomes of Different Two-Stent Techniques With Second-Generation Drug-Eluting Stents for Unprotected Left Main Bifurcation Disease: Insights From the FAILS-2 Study.
Pavani M; Conrotto F; Cerrato E; D'Ascenzo F; Kawamoto H; Núñez-Gil IJ; Pennone M; Garbo R; Tomassini F; Colombo F; Scacciatella P; Varbella F; Chieffo A; Colombo A; Escaned J
J Invasive Cardiol; 2018 Aug; 30(8):276-281. PubMed ID: 30068784
[TBL] [Abstract][Full Text] [Related]
10. First-in-man study of dedicated bifurcation sirolimus-eluting stent: 12-month results of BiOSS LIM® Registry.
Gil RJ; Bil J; Vassiliev D; Iñigo Garcia LA
J Interv Cardiol; 2015 Feb; 28(1):51-60. PubMed ID: 25689548
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcome after crush versus culotte stenting of coronary artery bifurcation lesions: the Nordic Stent Technique Study 36-month follow-up results.
Kervinen K; Niemelä M; Romppanen H; Erglis A; Kumsars I; Maeng M; Holm NR; Lassen JF; Gunnes P; Stavnes S; Jensen JS; Galløe A; Narbute I; Sondore D; Christiansen EH; Ravkilde J; Steigen TK; Mannsverk J; Thayssen P; Hansen KN; Helqvist S; Vikman S; Wiseth R; Aarøe J; Jokelainen J; Thuesen L;
JACC Cardiovasc Interv; 2013 Nov; 6(11):1160-5. PubMed ID: 24262616
[TBL] [Abstract][Full Text] [Related]
12. First-in-man study of paclitaxel-eluting stent BiOSS (Bifurcation Optimisation Stent System) dedicated for coronary bifurcation stenoses: three months results.
Gil RJ; Vassiliev D; Michałek A; Kern A; Formuszewicz R; Dobrzycki S; Lesiak M; Wójcik J; Kardaszewicz P; Lekston A
Kardiol Pol; 2012; 70(1):45-52. PubMed ID: 22267425
[TBL] [Abstract][Full Text] [Related]
13. Double Kissing Crush Versus Provisional Stenting for Left Main Distal Bifurcation Lesions: DKCRUSH-V Randomized Trial.
Chen SL; Zhang JJ; Han Y; Kan J; Chen L; Qiu C; Jiang T; Tao L; Zeng H; Li L; Xia Y; Gao C; Santoso T; Paiboon C; Wang Y; Kwan TW; Ye F; Tian N; Liu Z; Lin S; Lu C; Wen S; Hong L; Zhang Q; Sheiban I; Xu Y; Wang L; Rab TS; Li Z; Cheng G; Cui L; Leon MB; Stone GW
J Am Coll Cardiol; 2017 Nov; 70(21):2605-2617. PubMed ID: 29096915
[TBL] [Abstract][Full Text] [Related]
14. Acute and long-term results of percutaneous coronary intervention of bifurcation lesions with the dedicated Bioss Lim C stent: the Italian BIfurcation Observational Spontaneous Study (IBIOSS).
Briguori C; Capodanno D; Contarini M; Donahue ME; Evola S; Garro N; Greco F; LA Manna A; Murè P; Nicosia A; Migliore G; Sacchetta G; Signore N; Tamburino C; Vizzari G; Biondi-Zoccai G
Minerva Med; 2024 Apr; 115(2):171-177. PubMed ID: 38536058
[TBL] [Abstract][Full Text] [Related]
15. Clinical and Angiographic Outcomes Comparison of Patients With Left Main Vs Non-Left Main Bifurcation Lesions Treated With Percutaneous Coronary Intervention With Second-Generation Drug-Eluting Stents.
Vergara R; Valenti R; Migliorini A; Ciabatti M; Grazia De Gregorio M; Taborchi G; Morini S; Rondine R; Martone R; Antoniucci D
J Invasive Cardiol; 2018 Dec; 30(12):443-446. PubMed ID: 30504512
[TBL] [Abstract][Full Text] [Related]
16. Clinical outcomes of a dedicated bifurcation stent system.
Sivalingam J; Mazhar MW; Chaddad RA; Fouladvand F; Cortese B
Cardiovasc Revasc Med; 2024 Feb; 59():21-26. PubMed ID: 37666716
[TBL] [Abstract][Full Text] [Related]
17. Dedicated bifurcation paclitaxel-eluting stent BiOSS Expert® in the treatment of distal left main stem stenosis.
Bil J; Gil RJ; Vassilev D; Rzezak J; Kulawik T; Pawlowski T
J Interv Cardiol; 2014 Jun; 27(3):242-51. PubMed ID: 24708143
[TBL] [Abstract][Full Text] [Related]
18. Long-term outcomes after percutaneous revascularization of complex coronary bifurcation lesions using a dedicated self-expanding biolimus-eluting stent system.
Triantafyllis AS; Bennett J; Pagourelias E; McCutcheon K; Adriaenssens T; Sinnaeve PR; Desmet W; Dubois C
Cardiol J; 2018; 25(4):470-478. PubMed ID: 29240962
[TBL] [Abstract][Full Text] [Related]
19. A multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in bifurcation lesions treated with a single-stenting technique: six-month angiographic and 12-month clinical results of the drug-eluting balloon in bifurcations trial.
Stella PR; Belkacemi A; Dubois C; Nathoe H; Dens J; Naber C; Adriaenssens T; van Belle E; Doevendans P; Agostoni P
Catheter Cardiovasc Interv; 2012 Dec; 80(7):1138-46. PubMed ID: 22422607
[TBL] [Abstract][Full Text] [Related]
20. Differential prognostic impact of treatment strategy among patients with left main versus non-left main bifurcation lesions undergoing percutaneous coronary intervention: results from the COBIS (Coronary Bifurcation Stenting) Registry II.
Song YB; Hahn JY; Yang JH; Choi SH; Choi JH; Lee SH; Jeong MH; Kim HS; Lee JH; Yu CW; Rha SW; Jang Y; Yoon JH; Tahk SJ; Seung KB; Oh JH; Park JS; Gwon HC
JACC Cardiovasc Interv; 2014 Mar; 7(3):255-63. PubMed ID: 24529936
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
